Neurology Alert – April 1, 2014
April 1, 2014
View Issues
-
Monoclonal Amyloid Antibodies for the Treatment of Alzheimer’s Disease: More Disappointment
Current trials with amyloid antibodies have not shown clinical benefit, but the results suggest that treating patients earlier in the course, or during the presymptomatic period, might be beneficial. -
Optic and Auditory Involvement in Demyelinating Neuropathy
-
Severe Childhood Neuronopathy that Responds to Riboflavin
-
Bevacizumab for Newly Diagnosed Glioblastoma
-
The Importance of the CSF Specimen for Antibody Determination in NMDA Receptor Encephalitis